Cash for tests: study tests whether money boosts HIV screening in vulnerable women
NCT ID NCT03768986
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested whether offering a $25 to $40 incentive would encourage more African American, Latina, and low-income women to get tested for HIV. Over 300 women were randomly assigned to receive either standard referral and education or the same plus a monetary reward for testing. The goal was to see if the incentive increased testing rates and repeat testing over a year.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- monetary incentive for HIV testing
- What this could lead to
- If effective, this approach could be widely adopted by community organizations to increase HIV testing and early diagnosis among high-risk women.
- What could go wrong
- This is a completed behavioral study, not a drug trial. The incentive may not lead to sustained testing behavior, and results may not apply to all communities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTINGENCY MANAGEMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UConn Health
Farmington, Connecticut, 06030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?